DUOT Duos Technologies Group | $9.14 -4.3% | 9/14/2026 | | Boost Price Target | $22.00 ➝ $24.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Duos Technologies Group (NASDAQ:DUOT) on 9/14/2026 |
NTRP NextTrip | $1.93 +3.2% | 9/14/2026 | | Boost Price Target | $7.50 ➝ $7.75 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of NextTrip (NASDAQ:NTRP) on 9/14/2026 |
PDEX Pro-Dex | $71.77 -1.7% | 9/11/2026 | | Boost Price Target | $70.00 ➝ $74.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Pro-Dex (NASDAQ:PDEX) on 9/11/2026 |
LIQT LiqTech International | $0.61 -3.5% | 9/4/2026 | | Lower Price Target | $1.30 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of LiqTech International (NASDAQ:LIQT) on 9/4/2026 |
GNSS Genasys | $1.48 -0.7% | 8/28/2026 | | Lower Price Target | $6.00 ➝ $5.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Genasys (NASDAQ:GNSS) on 8/28/2026 |
QUBT Quantum Computing | $8.96 -2.2% | 8/26/2026 | | Boost Price Target | $30.00 ➝ $32.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Quantum Computing (NASDAQ:QUBT) on 8/26/2026 |
TZOO Travelzoo | $5.58 +1.3% | 8/20/2026 | | Lower Price Target | $23.00 ➝ $20.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Travelzoo (NASDAQ:TZOO) on 8/20/2026 |
DUOT Duos Technologies Group | $9.14 -4.3% | 6/15/2026 | | Boost Price Target | $17.00 ➝ $22.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Duos Technologies Group (NASDAQ:DUOT) on 6/15/2026 |
KSCP Knightscope | $0.91 +1.2% | 6/15/2026 | | Lower Price Target | $26.00 ➝ $23.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Knightscope (NASDAQ:KSCP) on 6/15/2026 |
QUBT Quantum Computing | $8.96 -2.2% | 6/15/2026 | | Boost Price Target | $27.00 ➝ $30.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Quantum Computing (NASDAQ:QUBT) on 6/15/2026 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
AYTU Aytu BioPharma | $2.28 -1.3% | 6/11/2026 | | Boost Price Target | $14.00 ➝ $14.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Aytu BioPharma (NASDAQ:AYTU) on 6/11/2026 |
OTLK Oncobiologics | $0.64 -2.4% | 6/11/2026 | | Boost Price Target | $6.00 ➝ $10.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Oncobiologics (NASDAQ:OTLK) on 6/11/2026 |
NTRP NextTrip | $1.93 +3.2% | 6/10/2026 | | Boost Price Target | $7.00 ➝ $7.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of NextTrip (NASDAQ:NTRP) on 6/10/2026 |
ALLR Allarity Therapeutics | $1.03 -5.5% | 6/8/2026 | | Boost Price Target | $9.75 ➝ $10.25 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Allarity Therapeutics (NASDAQ:ALLR) on 6/8/2026 |
CING Cingulate | $4.83 -4.5% | 6/8/2026 | | Lower Price Target | $55.00 ➝ $52.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Cingulate (NASDAQ:CING) on 6/8/2026 |
IGC IGC Pharma | $0.28 +0.5% | 6/8/2026 | | Boost Price Target | $5.25 ➝ $5.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of IGC Pharma (NYSEAMERICAN:IGC) on 6/8/2026 |
INTZ Intrusion | $0.71 -2.7% | 6/8/2026 | | Lower Price Target | $10.50 ➝ $9.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Intrusion (NASDAQ:INTZ) on 6/8/2026 |
LUCD Lucid Diagnostics | $0.83 -1.4% | 6/8/2026 | | Boost Price Target | $9.00 ➝ $9.25 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Lucid Diagnostics (NASDAQ:LUCD) on 6/8/2026 |
MYO Myomo | $1.61 -3.6% | 6/8/2026 | | Boost Price Target | $9.50 ➝ $10.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Myomo (NYSEAMERICAN:MYO) on 6/8/2026 |
PAVM PAVmed | $3.85 -0.8% | 6/8/2026 | | Lower Price Target | $65.00 ➝ $56.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of PAVmed (NASDAQ:PAVM) on 6/8/2026 |
PSTV Plus Therapeutics | $1.87 -4.1% | 6/8/2026 | | Lower Price Target | $65.00 ➝ $57.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Plus Therapeutics (NASDAQ:PSTV) on 6/8/2026 |
GNSS Genasys | $1.48 -0.7% | 6/2/2026 | | Boost Price Target | $5.50 ➝ $6.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Genasys (NASDAQ:GNSS) on 6/2/2026 |
RNXT RenovoRx | $1.66 -1.2% | 6/1/2026 | | Boost Price Target | $13.50 ➝ $14.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of RenovoRx (NASDAQ:RNXT) on 6/1/2026 |
AMTX Aemetis | $1.79 +1.1% | 5/22/2026 | | Boost Price Target | $21.00 ➝ $22.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Aemetis (NASDAQ:AMTX) on 5/22/2026 |
TZOO Travelzoo | $5.58 +1.3% | 5/22/2026 | | Boost Price Target | $22.00 ➝ $23.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Travelzoo (NASDAQ:TZOO) on 5/22/2026 |
LIQT LiqTech International | $0.61 -3.5% | 5/21/2026 | | Boost Price Target | $4.30 ➝ $4.40 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of LiqTech International (NASDAQ:LIQT) on 5/21/2026 |
PDEX Pro-Dex | $71.77 -1.7% | 5/12/2026 | | Boost Price Target | $56.00 ➝ $70.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Pro-Dex (NASDAQ:PDEX) on 5/12/2026 |
NRXP NRx Pharmaceuticals | $2.99 -1.3% | 4/27/2026 | | Boost Price Target | $48.00 ➝ $49.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 4/27/2026 |
DUOT Duos Technologies Group | $9.14 -4.3% | 4/17/2026 | | Boost Price Target | $14.00 ➝ $17.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Duos Technologies Group (NASDAQ:DUOT) on 4/17/2026 |
KSCP Knightscope | $0.91 +1.2% | 4/15/2026 | | Boost Price Target | $25.00 ➝ $26.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Knightscope (NASDAQ:KSCP) on 4/15/2026 |
ALLR Allarity Therapeutics | $1.03 -5.5% | 4/10/2026 | | Boost Price Target | $9.50 ➝ $9.75 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Allarity Therapeutics (NASDAQ:ALLR) on 4/10/2026 |
ATOS Atossa Genetics | $1.90 -7.3% | 4/10/2026 | | Lower Price Target | $120.00 ➝ $24.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Atossa Genetics (NASDAQ:ATOS) on 4/10/2026 |
INTZ Intrusion | $0.71 -2.7% | 4/9/2026 | | Lower Price Target | $12.50 ➝ $10.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Intrusion (NASDAQ:INTZ) on 4/9/2026 |
LUCD Lucid Diagnostics | $0.83 -1.4% | 4/9/2026 | | Boost Price Target | $8.25 ➝ $9.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Lucid Diagnostics (NASDAQ:LUCD) on 4/9/2026 |
PAVM PAVmed | $3.85 -0.8% | 4/9/2026 | | Lower Price Target | $510.00 ➝ $65.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of PAVmed (NASDAQ:PAVM) on 4/9/2026 |
PSTV Plus Therapeutics | $1.87 -4.1% | 4/9/2026 | | Lower Price Target | $475.00 ➝ $65.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Plus Therapeutics (NASDAQ:PSTV) on 4/9/2026 |
RNXT RenovoRx | $1.66 -1.2% | 4/9/2026 | | Boost Price Target | $13.00 ➝ $13.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of RenovoRx (NASDAQ:RNXT) on 4/9/2026 |
AMTX Aemetis | $1.79 +1.1% | 4/8/2026 | | Boost Price Target | $20.00 ➝ $21.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Aemetis (NASDAQ:AMTX) on 4/8/2026 |
CING Cingulate | $4.83 -4.5% | 4/8/2026 | | Lower Price Target | $58.00 ➝ $55.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Cingulate (NASDAQ:CING) on 4/8/2026 |
IGC IGC Pharma | $0.28 +0.5% | 4/8/2026 | | Boost Price Target | $5.00 ➝ $5.25 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of IGC Pharma (NYSEAMERICAN:IGC) on 4/8/2026 |
The REAL Reason Trump is Invading Iran (Ad) For a moment…
Forget about Trump’s ties to Israel.
Forget about reports of Iran’s nuclear program.
Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason. Click here to find out what it is. |
HSCS HeartSciences | $4.73 +2.2% | 3/24/2026 | | Lower Price Target | $9.00 ➝ $8.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of HeartSciences (NASDAQ:HSCS) on 3/24/2026 |
GNSS Genasys | $1.48 -0.7% | 3/11/2026 | | Boost Price Target | $5.25 ➝ $5.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Genasys (NASDAQ:GNSS) on 3/11/2026 |
OTLK Oncobiologics | $0.64 -2.4% | 3/11/2026 | | Lower Price Target | $10.00 ➝ $6.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Oncobiologics (NASDAQ:OTLK) on 3/11/2026 |
LIQT LiqTech International | $0.61 -3.5% | 3/10/2026 | | Boost Price Target | $4.20 ➝ $4.30 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of LiqTech International (NASDAQ:LIQT) on 3/10/2026 |
NTRP NextTrip | $1.93 +3.2% | 3/2/2026 | | Initiated Coverage | $7.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of NextTrip (NASDAQ:NTRP) on 3/2/2026 |
IGC IGC Pharma | $0.28 +0.5% | 2/23/2026 | | Boost Price Target | $4.75 ➝ $5.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of IGC Pharma (NYSEAMERICAN:IGC) on 2/23/2026 |
RNXT RenovoRx | $1.66 -1.2% | 2/17/2026 | | Boost Price Target | $12.50 ➝ $13.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of RenovoRx (NASDAQ:RNXT) on 2/17/2026 |
NRXP NRx Pharmaceuticals | $2.99 -1.3% | 1/2/2026 | | Reiterated Rating | $47.00 ➝ $48.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 1/2/2026 |
DUOT Duos Technologies Group | $9.14 -4.3% | 12/30/2025 | | Boost Price Target | $11.50 ➝ $14.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Duos Technologies Group (NASDAQ:DUOT) on 12/30/2025 |
GNSS Genasys | $1.48 -0.7% | 12/22/2025 | | Lower Price Target | $5.75 ➝ $5.25 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Genasys (NASDAQ:GNSS) on 12/22/2025 |
HSCS HeartSciences | $4.73 +2.2% | 12/22/2025 | | Boost Price Target | $9.00 ➝ $9.20 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of HeartSciences (NASDAQ:HSCS) on 12/22/2025 |
OTLK Oncobiologics | $0.64 -2.4% | 12/22/2025 | | Boost Price Target | $8.00 ➝ $10.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Oncobiologics (NASDAQ:OTLK) on 12/22/2025 |
QUBT Quantum Computing | $8.96 -2.2% | 12/22/2025 | | Lower Price Target | $40.00 ➝ $25.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Quantum Computing (NASDAQ:QUBT) on 12/22/2025 |
KSCP Knightscope | $0.91 +1.2% | 12/11/2025 | | Lower Price Target | $27.00 ➝ $25.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Knightscope (NASDAQ:KSCP) on 12/11/2025 |
AYTU Aytu BioPharma | $2.28 -1.3% | 12/10/2025 | | Boost Price Target | $12.50 ➝ $13.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Aytu BioPharma (NASDAQ:AYTU) on 12/10/2025 |
LUCD Lucid Diagnostics | $0.83 -1.4% | 12/10/2025 | | Boost Price Target | $8.00 ➝ $8.25 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Lucid Diagnostics (NASDAQ:LUCD) on 12/10/2025 |
PAVM PAVmed | $3.85 -0.8% | 12/10/2025 | | Lower Price Target | $600.00 ➝ $510.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of PAVmed (NASDAQ:PAVM) on 12/10/2025 |
ALLR Allarity Therapeutics | $1.03 -5.5% | 12/9/2025 | | Boost Price Target | $9.25 ➝ $9.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Allarity Therapeutics (NASDAQ:ALLR) on 12/9/2025 |
IGC IGC Pharma | $0.28 +0.5% | 12/9/2025 | | Boost Price Target | $4.50 ➝ $4.75 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of IGC Pharma (NYSEAMERICAN:IGC) on 12/9/2025 |
ATOS Atossa Genetics | $1.90 -7.3% | 12/8/2025 | | Boost Price Target | $116.25 ➝ $120.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Atossa Genetics (NASDAQ:ATOS) on 12/8/2025 |
CING Cingulate | $4.83 -4.5% | 12/8/2025 | | Lower Price Target | $62.00 ➝ $58.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Cingulate (NASDAQ:CING) on 12/8/2025 |
INTZ Intrusion | $0.71 -2.7% | 12/8/2025 | | Boost Price Target | $12.00 ➝ $12.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Intrusion (NASDAQ:INTZ) on 12/8/2025 |
MYO Myomo | $1.61 -3.6% | 11/21/2025 | | Lower Price Target | $10.50 ➝ $10.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Myomo (NYSEAMERICAN:MYO) on 11/21/2025 |
PSTV Plus Therapeutics | $1.87 -4.1% | 11/21/2025 | | Lower Price Target | $525.00 ➝ $475.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Plus Therapeutics (NASDAQ:PSTV) on 11/21/2025 |
RNXT RenovoRx | $1.66 -1.2% | 11/21/2025 | | Boost Price Target | $12.00 ➝ $12.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of RenovoRx (NASDAQ:RNXT) on 11/21/2025 |
LIQT LiqTech International | $0.61 -3.5% | 11/20/2025 | | Boost Price Target | $4.00 ➝ $4.20 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of LiqTech International (NASDAQ:LIQT) on 11/20/2025 |
AMTX Aemetis | $1.79 +1.1% | 11/19/2025 | | Lower Price Target | $21.00 ➝ $20.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Aemetis (NASDAQ:AMTX) on 11/19/2025 |
TZOO Travelzoo | $5.58 +1.3% | 11/19/2025 | | Lower Price Target | $26.00 ➝ $23.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Travelzoo (NASDAQ:TZOO) on 11/19/2025 |
NRXP NRx Pharmaceuticals | $2.99 -1.3% | 10/30/2025 | | Boost Price Target | $46.00 ➝ $47.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 10/30/2025 |
AMTX Aemetis | $1.79 +1.1% | 10/6/2025 | | Boost Price Target | $20.00 ➝ $21.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Aemetis (NASDAQ:AMTX) on 10/6/2025 |
GNSS Genasys | $1.48 -0.7% | 10/6/2025 | | Boost Price Target | $5.50 ➝ $5.75 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Genasys (NASDAQ:GNSS) on 10/6/2025 |
INTZ Intrusion | $0.71 -2.7% | 10/6/2025 | | Boost Price Target | $11.00 ➝ $12.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Intrusion (NASDAQ:INTZ) on 10/6/2025 |
KSCP Knightscope | $0.91 +1.2% | 10/6/2025 | | Boost Price Target | $26.00 ➝ $27.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Knightscope (NASDAQ:KSCP) on 10/6/2025 |
LUCD Lucid Diagnostics | $0.83 -1.4% | 10/6/2025 | | Boost Price Target | $7.75 ➝ $8.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Lucid Diagnostics (NASDAQ:LUCD) on 10/6/2025 |
PAVM PAVmed | $3.85 -0.8% | 10/6/2025 | | Boost Price Target | $570.00 ➝ $600.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of PAVmed (NASDAQ:PAVM) on 10/6/2025 |
PSTV Plus Therapeutics | $1.87 -4.1% | 10/6/2025 | | Boost Price Target | $512.50 ➝ $525.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Plus Therapeutics (NASDAQ:PSTV) on 10/6/2025 |
QUBT Quantum Computing | $8.96 -2.2% | 10/3/2025 | | Boost Price Target | $22.00 ➝ $40.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Quantum Computing (NASDAQ:QUBT) on 10/3/2025 |
HSCS HeartSciences | $4.73 +2.2% | 10/1/2025 | | Lower Price Target | $15.00 ➝ $9.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of HeartSciences (NASDAQ:HSCS) on 10/1/2025 |
ALLR Allarity Therapeutics | $1.03 -5.5% | 9/26/2025 | | Boost Price Target | $9.00 ➝ $9.25 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Allarity Therapeutics (NASDAQ:ALLR) on 9/26/2025 |
AYTU Aytu BioPharma | $2.28 -1.3% | 9/25/2025 | | Boost Price Target | $12.00 ➝ $12.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Aytu BioPharma (NASDAQ:AYTU) on 9/25/2025 |
DUOT Duos Technologies Group | $9.14 -4.3% | 9/24/2025 | | Boost Price Target | $11.00 ➝ $11.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Duos Technologies Group (NASDAQ:DUOT) on 9/24/2025 |
ATOS Atossa Genetics | $1.90 -7.3% | 9/22/2025 | | Boost Price Target | $112.50 ➝ $116.25 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Atossa Genetics (NASDAQ:ATOS) on 9/22/2025 |
MYO Myomo | $1.61 -3.6% | 9/22/2025 | | Lower Price Target | $11.50 ➝ $10.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Myomo (NYSEAMERICAN:MYO) on 9/22/2025 |
OTLK Oncobiologics | $0.64 -2.4% | 9/22/2025 | | Lower Price Target | $21.00 ➝ $8.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Oncobiologics (NASDAQ:OTLK) on 9/22/2025 |
IGC IGC Pharma | $0.28 +0.5% | 8/26/2025 | | Boost Price Target | $4.25 ➝ $4.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of IGC Pharma (NYSEAMERICAN:IGC) on 8/26/2025 |
TZOO Travelzoo | $5.58 +1.3% | 8/26/2025 | | Boost Price Target | $25.00 ➝ $26.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Travelzoo (NASDAQ:TZOO) on 8/26/2025 |
RNXT RenovoRx | $1.66 -1.2% | 8/25/2025 | | Boost Price Target | $11.50 ➝ $12.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of RenovoRx (NASDAQ:RNXT) on 8/25/2025 |
CING Cingulate | $4.83 -4.5% | 8/22/2025 | | Boost Price Target | $61.00 ➝ $62.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Cingulate (NASDAQ:CING) on 8/22/2025 |
ALLR Allarity Therapeutics | $1.03 -5.5% | 7/28/2025 | | Initiated Coverage | $9.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Allarity Therapeutics (NASDAQ:ALLR) on 7/28/2025 |
AYTU Aytu BioPharma | $2.28 -1.3% | 6/30/2025 | | Initiated Coverage | $12.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Aytu BioPharma (NASDAQ:AYTU) on 6/30/2025 |
The REAL Reason Trump is Invading Iran (Ad) For a moment…
Forget about Trump’s ties to Israel.
Forget about reports of Iran’s nuclear program.
Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason. Click here to find out what it is. |
QMCO Quantum | $31.68 +7.4% | 6/18/2025 | | Reiterated Rating | | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Quantum (NASDAQ:QMCO) on 6/18/2025 |
DUOT Duos Technologies Group | $9.14 -4.3% | 6/16/2025 | | Boost Price Target | $9.00 ➝ $11.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Duos Technologies Group (NASDAQ:DUOT) on 6/16/2025 |
LIQT LiqTech International | $0.61 -3.5% | 6/16/2025 | | Boost Price Target | $3.40 ➝ $3.60 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of LiqTech International (NASDAQ:LIQT) on 6/16/2025 |
AMTX Aemetis | $1.79 +1.1% | 6/6/2025 | | Boost Price Target | $19.00 ➝ $20.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Aemetis (NASDAQ:AMTX) on 6/6/2025 |
ATOS Atossa Genetics | $1.90 -7.3% | 6/6/2025 | | Boost Price Target | $108.75 ➝ $112.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Atossa Genetics (NASDAQ:ATOS) on 6/6/2025 |
GNSS Genasys | $1.48 -0.7% | 6/6/2025 | | Lower Price Target | $6.00 ➝ $5.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Genasys (NASDAQ:GNSS) on 6/6/2025 |
KSCP Knightscope | $0.91 +1.2% | 6/6/2025 | | Lower Price Target | $30.00 ➝ $26.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Knightscope (NASDAQ:KSCP) on 6/6/2025 |
LUCD Lucid Diagnostics | $0.83 -1.4% | 6/6/2025 | | Boost Price Target | $7.50 ➝ $7.75 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Lucid Diagnostics (NASDAQ:LUCD) on 6/6/2025 |
OTLK Oncobiologics | $0.64 -2.4% | 6/6/2025 | | Lower Price Target | $24.00 ➝ $21.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Oncobiologics (NASDAQ:OTLK) on 6/6/2025 |
PAVM PAVmed | $3.85 -0.8% | 6/6/2025 | | Lower Price Target | $585.00 ➝ $570.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of PAVmed (NASDAQ:PAVM) on 6/6/2025 |